Shaheen Applauds Selection of 15 More Drugs for Medicare Price Negotiations, Lowering Prescription Drug Costs for Granite Staters

(Washington, DC) - U.S. Senator Jeanne Shaheen (D-NH) applauded the selection of 15 more prescription drugs covered under Medicare Part D for direct price negotiations with pharmaceutical companies, helping lower costs for Americans who rely on these medications. Nationwide, 5.3 million Americans with Medicare Part D coverage take prescription drugs set for negotiation in 2025 to treat a variety of conditions, including cancer, type 2 diabetes and asthma. Shaheen was a key supporter of measures in the Inflation Reduction Act that empowered Medicare to directly negotiate the prices for certain high-cost prescription drugs for the first time.